PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vesting depends on the new employees remaining with PTC through the applicable vesting dates.

Rhea-AI Summary

PTC Therapeutics (PTCT) approved stock options and restricted stock units for 37 new employees on September 22, 2026. The grants comprise options to purchase 51,270 common shares and 37,995 restricted stock units, each representing the right to receive one common share upon vesting. The options have an exercise price of $65.96 per share, equal to the closing share price on the grant date.

The Compensation Committee approved the awards under Nasdaq Listing Rule 5635(c)(4) as inducements to accept employment. The options have a 10-year term. Both types of awards vest over four years, subject to continued service through the applicable vesting dates.

Key Figures

Stock options granted: 51,270 shares Restricted stock units granted: 37,995 RSUs Recipients: 37 new employees +4 more

Stock options granted

51,270 shares

Inducement awards to new employees

Restricted stock units granted

37,995 RSUs

Inducement awards to new employees

Recipients

37 new employees

Inducement awards

Option exercise price

$65.96 per share

Stock options granted Sept. 22, 2026

Option term

10 years

Stock option awards

Option vesting schedule

25% at the first anniversary; 6.25% at the end of each subsequent three-month period

Over four years, subject to continued service

RSU vesting schedule

25% on each annual anniversary

Over four years, subject to continued service

Key Terms

non-statutory stock options, restricted stock units, nasdaq listing rule 5635(c)(4)

3 terms

non-statutory stock options financial

"approved non-statutory stock options to purchase an aggregate of 51,270 shares"

Non-statutory stock options are a type of reward that companies give to employees, allowing them to buy company shares at a set price within a certain period. Unlike formal or government-approved plans, these options are more flexible but may have different tax implications. For investors, they can influence a company's stock price and financial health, making them an important factor to consider.

restricted stock units financial

"and 37,995 restricted stock units ("RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WARREN, N.J., Sept. 25, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept. 22, 2026, the company approved non-statutory stock options to purchase an aggregate of 51,270 shares of its common stock and 37,995 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to 37 new employees. The awards were made pursuant to the Nasdaq inducement grant exception as a component of the new hires' employment compensation.

The inducement grants were approved by PTC's Compensation Committee on Sept. 22, 2026, and are being made as an inducement material to each employee's acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).

All stock option awards have an exercise price of $65.96 per share, the closing price of PTC's common stock on Sept. 22, 2026, the date of the grant. The stock options each have a 10-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee's new hire date and 6.25% of the original number of shares vesting at the end of each subsequent three-month period thereafter until fully vested, subject to the employee's continued service with the company through the applicable vesting dates. The RSUs each will vest over four years with 25% of the original number of shares vesting on each annual anniversary of the applicable employee's new hire date until fully vested, subject to the employee's continued service with the company through the applicable vesting dates.

ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Instagram and Facebook.

For more information please contact:

Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302890020.html

SOURCE PTC Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How do PTC Therapeutics’ September 2026 inducement grants vest?

The options and restricted stock units vest over four years, subject to continued service through each applicable vesting date. For options, 25% of the original shares vest on the first anniversary of the employee’s new hire date, followed by 6.25% at the end of each subsequent three-month period. For restricted stock units, 25% vests on each annual anniversary of the new hire date.